Sarah Pringle

The Santa Monica buyout firm bought Symplr in 2018 in a transaction valuing the healthcare software company at about $550 million.

Underscoring sponsors' appetite for scale healthcare software providers in large markets, TPG is set to remain a 50 percent shareholder almost four years into its investment.

PPD, another H&F portfolio company that provides outsourced pharma services, returned to the public markets in February at an initial EV of approximately $14bn.  

The Boston-based company provides caregivers with education, support and case management for seniors with complex care needs.

H&F-backed MultiPlan merges with a SPAC in an $11 billion deal.

While the highly anticipated MAE trial is called off, Advent's revised agreement for Forescout narrows from $1.9bn to to $1.43bn. 

A deal is expected to value the provider of contract manufacturing services and packaging for pharmaceutical companies in the $2.5bn to $3bn range.

The process for Senior LIFE comes on the heels of Apax Partners’ acquisition of a stake in WCAS-backed InnovAge, one of the largest PACE organizations in the country.

Deal conversations pick up in the healthcare landscape.

The Goldman-run process could produce a deal as early as this month, a source said.